Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Ching Wang

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Gut Microbes|October 7, 2022
<i>Helicobacter pylori</i> employs a general protein glycosylation system for the modification of outer membrane adhesinsKai-Wen Teng, Kai-Siang Hsieh, Ji-Shiuan Hung, et al.
Cellular and Molecular Life Sciences : CMLS|April 21, 2025
KDM4C works in concert with GATA1 to regulate heme metabolism in head and neck squamous cell carcinomaMeng-Jen Wu, Shan-Min Yang, Wei-Kai Fang, et al.
Molecular Oncology|August 3, 2020
Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradationCheng-Han Lin, Tai-I Hsu, Pei-Yu Chiou, et al.
Journal of Medicinal Chemistry|June 28, 2014
KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitorChia-Han Chu, Ling-Yu Wang, Kai-Cheng Hsu, et al.
Gut Microbes|October 6, 2024
<i>Helicobacter pylori</i> PldA modulates TNFR1-mediated p38 signaling pathways to regulate macrophage responses for its survivalWei Yang Sit, Mei-Ling Cheng, Tsan-Jan Chen, et al.
Oncotarget|March 19, 2016
Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instabilityTim Ting-Chung Yen, Anderson Yang, Wen-Tai Chiu, et al.
Journal of Biomedical Science|May 9, 2022
Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancerJai-Shin Liu, Wei-Kai Fang, Shan-Min Yang, et al.
Clinical and Translational Medicine|March 28, 2022
Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolismChing-Yu Lin, Bi-Juan Wang, Yu-Ke Fu, et al.
Therapeutic Advances in Medical Oncology|October 22, 2019
High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinomaCheng-Han Lin, Hao-Yi Li, Yu-Peng Liu, et al.
BMC Genomics|November 26, 2013
The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivationPei-Ching Chang, Chia-Yang Cheng, Mel Campbell, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Gut Microbes|October 7, 2022
<i>Helicobacter pylori</i> employs a general protein glycosylation system for the modification of outer membrane adhesinsKai-Wen Teng, Kai-Siang Hsieh, Ji-Shiuan Hung, et al.
Cellular and Molecular Life Sciences : CMLS|April 21, 2025
KDM4C works in concert with GATA1 to regulate heme metabolism in head and neck squamous cell carcinomaMeng-Jen Wu, Shan-Min Yang, Wei-Kai Fang, et al.
Molecular Oncology|August 3, 2020
Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradationCheng-Han Lin, Tai-I Hsu, Pei-Yu Chiou, et al.
Journal of Medicinal Chemistry|June 28, 2014
KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitorChia-Han Chu, Ling-Yu Wang, Kai-Cheng Hsu, et al.
Gut Microbes|October 6, 2024
<i>Helicobacter pylori</i> PldA modulates TNFR1-mediated p38 signaling pathways to regulate macrophage responses for its survivalWei Yang Sit, Mei-Ling Cheng, Tsan-Jan Chen, et al.
Oncotarget|March 19, 2016
Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instabilityTim Ting-Chung Yen, Anderson Yang, Wen-Tai Chiu, et al.
Journal of Biomedical Science|May 9, 2022
Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancerJai-Shin Liu, Wei-Kai Fang, Shan-Min Yang, et al.
Clinical and Translational Medicine|March 28, 2022
Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolismChing-Yu Lin, Bi-Juan Wang, Yu-Ke Fu, et al.
Therapeutic Advances in Medical Oncology|October 22, 2019
High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinomaCheng-Han Lin, Hao-Yi Li, Yu-Peng Liu, et al.
BMC Genomics|November 26, 2013
The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivationPei-Ching Chang, Chia-Yang Cheng, Mel Campbell, et al.
Pageof 11